{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:09:24Z","timestamp":1794254964034,"version":"4.9.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA24114"],"award-info":[{"award-number":["CA24114"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["RD21\/0017\/0022"],"award-info":[{"award-number":["RD21\/0017\/0022"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["RD24\/0014\/0037"],"award-info":[{"award-number":["RD24\/0014\/0037"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021-SGR-00877"],"award-info":[{"award-number":["2021-SGR-00877"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcyt.2026.102903","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:58:55Z","timestamp":1777183135000},"page":"102903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mesenchymal stromal cell-based therapy in the COVID-19 pandemic: results from an academic phase I\/II double-blind, randomized, placebo-controlled clinical trial and reflections for the field"],"prefix":"10.1016","volume":"28","author":[{"given":"Antoni","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1320-4427","authenticated-orcid":false,"given":"Judith","family":"Marin-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Adalia-Bartolome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Briones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2908-0748","authenticated-orcid":false,"given":"Merche","family":"Ibarz-Villamayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6118-8970","authenticated-orcid":false,"given":"Pedro","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Ma\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2930-0766","authenticated-orcid":false,"given":"Josep","family":"Trenado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Codinach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4016-0020","authenticated-orcid":false,"given":"Jesus","family":"Fern\u00e1ndez-Sojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0174-379X","authenticated-orcid":false,"given":"Ruth","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1105-8633","authenticated-orcid":false,"given":"Sergi","family":"Querol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0718-7993","authenticated-orcid":false,"given":"Joaqu\u00edn","family":"Delgadillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9719-5235","authenticated-orcid":false,"given":"Joaquim","family":"Vives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jcyt.2026.102903_bib0001","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3390\/ijerph22121807","article-title":"Global Health Governance and the WHO Pandemic Agreement: A Scoping Review of Challenges and Analysis of Reforms","volume":"22","author":"Abdel-Motaal","year":"2025","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jcyt.2026.102903_bib0002","article-title":"SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines","volume":"15","author":"Li","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcyt.2026.102903_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1469696","article-title":"Mesenchymal stem cell application in pulmonary disease treatment with emphasis on their interaction with lung-resident immune cells","volume":"15","author":"Hazrati","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102903_bib0004","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm3049","article-title":"The elusive nature and function of mesenchymal stem cells","volume":"12","author":"Nombela-Arrieta","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jcyt.2026.102903_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm.3028","article-title":"The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine","volume":"19","author":"Bianco","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102903_bib0006","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41409-020-0822-8","article-title":"Beyond chimerism analysis: methods for tracking a new generation of cell-based medicines","volume":"55","author":"Vives","year":"2020","journal-title":"Bone Marrow Transpl"},{"issue":"14","key":"10.1016\/j.jcyt.2026.102903_bib0007","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1073\/pnas.1432929100","article-title":"Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects","volume":"100","author":"Ortiz","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2026.102903_bib0008","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jcyt.2020.04.089","article-title":"Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential","volume":"22","author":"Khoury","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102903_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/17476348.2020.1679628","article-title":"The potential of mesenchymal stem cell therapy for chronic lung disease","volume":"14","author":"Cruz","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jcyt.2026.102903_bib0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fimmu.2017.00339","article-title":"Antimicrobial activity of mesenchymal stem cells: current status and new perspectives of antimicrobial peptide-based therapies","volume":"8","author":"Alcayaga-Miranda","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102903_bib0011","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"key":"10.1016\/j.jcyt.2026.102903_bib0012","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41392-020-00286-5","article-title":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial","volume":"5","author":"Meng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jcyt.2026.102903_bib0013","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/sctm.20-0472","article-title":"Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1\/2a, randomized controlled trial","volume":"10","author":"Lanzoni","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2026.102903_bib0014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40778-023-00231-6","article-title":"MSC-based cell therapy for COVID-19-associated ARDS and classical ARDS: comparative perspectives","volume":"10","author":"Weiss","year":"2024","journal-title":"Curr Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2026.102903_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcyt.2014.08.009","article-title":"Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells","volume":"17","author":"Watson","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102903_bib0023","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomized trials","volume":"10","author":"Moher","year":"2012","journal-title":"Int J Surg"},{"key":"10.1016\/j.jcyt.2026.102903_bib0016","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcyt.2015.10.001","article-title":"Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly","volume":"18","author":"Oliver-Vila","year":"2016","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.jcyt.2026.102903_bib0017","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/cells8050484","article-title":"Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton\u2019s Jelly","volume":"8","author":"Grau-Vorster","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2026.102903_bib0024","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10616-021-00474-3","article-title":"Towards the standardization of methods of tissue processing for the isolation of mesenchymal stromal cells for clinical use","volume":"73","author":"Garcia-Munoz","year":"2021","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jcyt.2026.102903_bib0025","first-page":"19","article-title":"Advances in translational orthopaedic research with species-specific multipotent mesenchymal stromal cells derived from the umbilical cord","volume":"36","author":"Ramallo","year":"2021","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.jcyt.2026.102903_bib0026","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12967-018-1659-4","article-title":"Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products","volume":"16","author":"Mirabel","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2026.102903_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1375493","article-title":"Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience","volume":"12","author":"Perez-Torres Lobato","year":"2024","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jcyt.2026.102903_bib0028","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12026-023-09385-1","article-title":"Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use","volume":"71","author":"Torrents","year":"2023","journal-title":"Immunol Res"},{"key":"10.1016\/j.jcyt.2026.102903_bib0029","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10616-017-0186-0","article-title":"Optimisation of a potency assay for the assessment of immunomodulative potential of clinical grade multipotent mesenchymal stromal cells","volume":"70","author":"Oliver-Vila","year":"2018","journal-title":"Cytotechnology"},{"issue":"12","key":"10.1016\/j.jcyt.2026.102903_bib0018","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jcyt.2023.08.001","article-title":"A management model in blood, tissue and cell establishments to ensure rapid and sustainable patient access to advanced therapy medicinal products in Europe","volume":"25","author":"Delgadillo","year":"2023","journal-title":"Cytotherapy"},{"issue":"13","key":"10.1016\/j.jcyt.2026.102903_bib0019","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.3390\/cells11132112","article-title":"The Quality Management Ecosystem in Cell Therapy in Catalonia (Spain): An Opportunity for Integrating Standards and Streamlining Quality Compliance","volume":"11","author":"Vives","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2026.102903_bib0020","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jcyt.2015.02.002","article-title":"Quality compliance in the shift from cell transplantation to cell therapy in non-pharma environments","volume":"17","author":"Vives","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102903_bib0021","first-page":"158","article-title":"SARS-CoV-2\/COVID-19 pandemic: first wave, impact, response and lessons learnt in a fully integrated Regional Blood and Tissue Bank. A narrative report","volume":"19","author":"Garcia-Lopez","year":"2021","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jcyt.2026.102903_bib0022","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcyt.2022.07.011","article-title":"A hub-and-spoke model to deliver effective access to chimeric antigen receptor T-cell therapy in a public health network: the Catalan blood and tissue bank experience","volume":"25","author":"Fernandez-Sojo","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102903_bib0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1164\/rccm.202201-0157OC","article-title":"A randomized trial of mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome from COVID-19","volume":"207","author":"Bowdish","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcyt.2026.102903_bib0031","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41409-024-02230-5","article-title":"Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomized controlled trial","volume":"59","author":"Mart\u00ednez-Mu\u00f1oz","year":"2024","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jcyt.2026.102903_bib0032","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13054-022-04287-4","article-title":"The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials","volume":"27","author":"Wang","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.jcyt.2026.102903_bib0033","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s12967-024-05358-6","article-title":"Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Lu","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2026.102903_bib0043","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1164\/rccm.202302-0297OC","article-title":"Repair of acute respiratory distress syndrome in COVID-19 by stromal cells (REALIST-COVID Trial): a multicenter, randomized, controlled clinical trial","volume":"208","author":"Gorman","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcyt.2026.102903_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2026.102854","article-title":"Cellular immunotherapy for COVID-19-induced acute respiratory distress syndrome: Results of the CIRCA-19 phase 1 safety and phase 2 randomized controlled trials","author":"English","year":"2026","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2026.102903_bib0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ymeth.2025.03.004","article-title":"Milking mesenchymal stem cells: updated protocols for cell lysate, secretome, and exosome extraction, and comparative analysis of their therapeutic potential","volume":"238","author":"Zununi Vahed","year":"2025","journal-title":"Methods"},{"key":"10.1016\/j.jcyt.2026.102903_bib0036","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13287-022-02743-0","article-title":"Clinical efficacy and mechanism of mesenchymal stromal cells in treatment of COVID-19","volume":"13","author":"Lu","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2026.102903_bib0037","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s12967-024-05358-6","article-title":"Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Lu","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2026.102903_bib0040","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s13287-025-04644-4","article-title":"Efficacy and safety of mesenchymal stem\/stromal cells and their derived extracellular vesicles for acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"16","author":"Wu","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2026.102903_bib0041","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/thorax-2023-220292","article-title":"Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS)","volume":"79","author":"Mehta","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.jcyt.2026.102903_bib0042","article-title":"Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up","volume":"29","author":"Saleh","year":"2022","journal-title":"Gene Rep"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102903_bib0044","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1164\/rccm.202411-2254OC","article-title":"Treatment with Allogeneic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multicenter Phase 2b Clinical Trial (STAT)","volume":"212","author":"Matthay","year":"2026","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcyt.2026.102903_bib0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13287-023-03573-4","article-title":"Plasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19","volume":"14","author":"Li","year":"2023","journal-title":"Stem Cell Res Ther"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:27:42Z","timestamp":1783337262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926008649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1465324926008649"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102903","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stromal cell-based therapy in the COVID-19 pandemic: results from an academic phase I\/II double-blind, randomized, placebo-controlled clinical trial and reflections for the field","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102903"}}